FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Remifentanil Hydrochloride Injection

  • U.S. Food and Drug Administration
  • August 20, 2026
  • ID: shortage-remifentanil-hydrochloride-injection-mylan-institutional-a-viatris-company-72078-034-01

Drug Shortage Details

Generic NameRemifentanil Hydrochloride Injection
Manufacturer / CompanyMylan Institutional, a Viatris Company
Therapeutic CategoryAnalgesia/Addiction
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code72078-034-01
Presentation & Dosage Form

Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)

Manufacturer Contact Info

800-796-9526


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.